Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Very few clinical trials have investigated the effect of topical acne treatment on scarring. OBJECTIVES: Our objective was to evaluate the efficacy of adapalene 0.3%/benzoyl peroxide 2.5% gel (A0.3/BPO2.5) in atrophic acne scar formation in patients with acne. METHODS: In this multicenter, randomized, investigator-blinded, vehicle-controlled study, subjects with moderate or severe facial acne (Investigator's Global Assessment [IGA] score 3 or 4; ≥ 25 inflammatory lesions; ten or more atrophic acne scars) applied A0.3/BPO2.5 or vehicle daily per half face for 24 weeks. Subjects with acne requiring systemic treatment were excluded. Assessments included investigator atrophic acne scar count, Scar Global Assessment (SGA), acne lesion count, IGA, skin roughness and skin texture, subject self-assessment of clinical acne-related scars and satisfaction questionnaire, tolerability, and safety. RESULTS: Included subjects (n = 67) had mainly moderate acne (92.5% IGA 3); mean scores at baseline were approximately 40 acne lesions and 12 scars per half face. By week 24, the change from baseline in total scar count was - 15.5% for A0.3/BPO2.5 versus + 14.4% for vehicle (approximately 30% difference), with a mean of 9.5 scars versus 13.3 per half face, respectively (p < 0.0001). For SGA at week 24, a total of 32.9% with A0.3/BPO2.5 versus 16.4% with vehicle (p < 0.01) were clear/almost clear. Inflammatory acne lesions decreased by 86.7% for A0.3/BPO2.5 versus 57.9% for vehicle (p < 0.0001), and 64.2 versus 19.4% of subjects, respectively, were IGA clear/almost clear (p < 0.0001) at week 24. Treatment-related AEs were reported by 20.9% for A0.3/BPO2.5 versus 9% for vehicle side, most commonly skin irritation (14.9 vs. 6%, respectively). CONCLUSIONS: Topical A0.3/BPO2.5 prevented and reduced atrophic scar formation. Scar count increased with vehicle (+ 14.4%) but decreased with A0.3/BPO2.5 (- 15.5%) over 24 weeks. TRIAL REGISTRY: ClinicalTrials.gov identifier NCT02735421.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Compared to vehicle at 12 weeks, a greater proportion of patients treated with combined BP and topical retinoid achieved IGA success in 3 RCTs (RR, 2.19 [1.77, 2.72]).63,64,109”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gollnick, H., Cunliffe, W., Berson, D., Dreno, B., Finlay, A., Leyden, J. J., Shalita, A. R., & Thiboutot, D. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.618 · Cited by 817
Self-citationRestoration of Collagen Formation in Photodamaged Human Skin by Tretinoin (Retinoic Acid)
Griffiths, C., Russman, A. N., Majmudar, G., Singer, R. S., Hamilton, T. A., & Voorhees, J. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290803 · Cited by 474
Scholz, C. F. P., & Kilian, M. (2016) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001367 · Cited by 463
Thiboutot, D. M., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., Bettoli, V., Casintahan, F., Chow, S., da Costa, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.078 · Cited by 418
Self-citationA clinical evaluation of acne scarring and its incidence
LAYTON, A. M., HENDERSON, C. A., & CUNLIFFE, W. J. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01200.x · Cited by 361
Kang, S., Cho, S., Chung, J. H., Hammerberg, C., Fisher, G. J., & Voorhees, J. J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62479-0 · Cited by 247
Trivedi, N. R., Gilliland, K. L., Zhao, W., Liu, W., & Thiboutot, D. M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700213 · Cited by 196
Why Topical Retinoids Are Mainstay of Therapy for Acne
Leyden, J., Stein-Gold, L., & Weiss, J. (2017) · Dermatology and Therapy · doi:10.1007/s13555-017-0185-2 · Cited by 164
Prevalence and Risk Factors of Acne Scarring Among Patients Consulting Dermatologists in the USA
Tan, J. K. L., Kang, S., & Leyden, J. (2017) · PubMed · Cited by 164
Self-citationA consensus‐based practical and daily guide for the treatment of acne patients
Gollnick, H. P. M., Bettoli, V., Lambert, J., Araviiskaia, E., Binić, I., Dessinioti, C., Galadari, I. H., Gancevičienė, R., İlter, N., Kaegi, M., et al. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13675 · Cited by 144
Self-citation
Cited by
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Self-citationManagement of Acne Vulgaris: A Review
Eichenfield, D. Z., Sprague, J., & Eichenfield, L. F. (2021) · JAMA · doi:10.1001/jama.2021.17633 · Cited by 389
Current Issues in the Treatment of Acne Vulgaris
Habeshian, K. A., & Cohen, B. A. (2020) · Pediatrics · doi:10.1542/peds.2019-2056l · Cited by 179
A Comprehensive Review of Acne Vulgaris
Mohiuddin, A. K. (2019) · Journal of Clinical Research in Dermatology · doi:10.15226/2378-1726/6/2/00186 · Cited by 126
Topical benzoyl peroxide for acne
Yang, Z., Zhang, Y., Mosler, E. L., Hu, J., Li, H., Zhang, Y., Liu, J., & Zhang, Q. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011154.pub2 · Cited by 89
Metadata
- Authors
- Dréno, B., Bissonnette, R., Gagné-Henley, A., Barankin, B., Lynde, C., Kerrouche, N., & Tan, J.
- Affiliations
- Inserm (FR)
- Innovaderm (Canada) (CA)
- Lynde Centre for Dermatology (CA)
- Galderma (France) (FR)
- Western University (CA)
- Corresponding author
- Dréno, Brigitte
- Venue
- American Journal of Clinical Dermatology
- Published
- 2018-03-16
- Volume
- 19
- Issue
- 2
- Pages
- 275-286
- ISSN
- 1175-0561 (ISSN-L)
- 1179-1888
- PMC
- PMC5978908
- OpenAlex
- W2794146536
- Semantic Scholar
- cceaf6387dc815eed32658a16e2b8976805dabf8
- Cited by
- 69
- References
- 31
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 9 · 2022: 10 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 4
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- American Journal of Clinical Dermatology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Galderma
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- atrophic acne scars, adapalene, benzoyl peroxide, topical acne treatment, facial acne, inflammatory acne lesions, skin texture, safety and tolerability, intraindividual comparison, acne, patient satisfaction, skin roughness
- MeSH terms
- Adapalene, Acne Vulgaris, Administration, Cutaneous, Adolescent, Adult, Atrophy, Benzoyl Peroxide, Cicatrix, Dermatologic Agents, Double-Blind Method, Drug Combinations, Face, Female, Gels, Humans, Male, Severity of Illness Index, Skin, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison. https://app.cochat.ai/papers/10.1007/s40257-018-0352-y
- The paper
- Dréno, B., Bissonnette, R., Gagné-Henley, A., Barankin, B., Lynde, C., Kerrouche, N., & Tan, J. (2018). Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison. American Journal of Clinical Dermatology. https://doi.org/10.1007/s40257-018-0352-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.